Rockland Immunochemicals, Inc.
Robert Hooper, Ph.D., is an accomplished scientist currently serving as the Associate Director and Head of Analytical Services at Rockland Immunochemicals, Inc. since September 2019. In this leadership role, Robert oversees 1D and 2DGE analyses during antibody development, ensuring data quality and supporting custom antibody generation for client-specific HCP projects. Prior experiences include serving as Principal Scientist and Senior Research Scientist at AVMBioMed, focusing on cancer biomarker discovery, and as Associate Research Scientist at Coriell Institute, investigating the dual function of CDK9. Robert's research journey began with a PhD from University College London, followed by postdoctoral work at Temple University studying calcium regulation in immune cells. With a robust educational foundation in pharmacology from the University of Bristol, Robert's expertise spans proteomics, cancer research, and transcriptional regulation.
Rockland Immunochemicals, Inc.
Rockland Immunochemicals is a biotechnology company that manufactures tools for basic, applied, and clinical research in functional genomics, gene therapy, and drug discovery markets. The company offers products, including antibodies, assay kits, proteins, and custom services.